Clinical research on Cyclosporine A in cancer treatment is ongoing. Several clinical trials are exploring its efficacy in combination with other chemotherapeutic agents. Early results have been promising, particularly in cases where traditional therapies have failed due to drug resistance. However, more extensive studies are needed to fully understand its potential and to establish standardized treatment protocols.
